MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2

Objective: Chemotherapy is a major therapeutic method for bladder urothelial carcinoma (BUC), which can effectively improve the prognosis of BUC patients, but the chemoresistance often leads to chemotherapy failure. This study will research the regulatory roles and molecular mechanism of miR-101-3p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bo, Xie, Dalong, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584933/
https://www.ncbi.nlm.nih.gov/pubmed/31258770
http://dx.doi.org/10.7150/jca.33117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584933/
https://www.ncbi.nlm.nih.gov/pubmed/31258770
http://dx.doi.org/10.7150/jca.33117

Ejemplares similares